Even with insurance, cancer treatment typically costs patients $4,500 to $6,000 or more per year in out-of-pocket expenses. That range comes from research by the American Cancer Society, which found costs exceeding $6,000 annually for breast, colorectal, and lung cancer patients with employer-sponsored insurance, and around $4,500 for prostate cancer patients. These are costs after insurance pays its share, and they’ve been climbing steadily, rising more than 15 percent across all cancer types in recent years.
Perhaps the most striking number: 47 percent of cancer patients and survivors report carrying medical debt related to their treatment, and 98 percent of those patients were insured when that debt was incurred. Insurance helps enormously, but it doesn’t eliminate the financial burden of cancer care.
What You’ll Actually Pay Depends on Your Plan
Your total cost comes down to three features of your insurance plan: the deductible (what you pay before insurance kicks in), coinsurance or copays (your share of each bill after the deductible), and the out-of-pocket maximum (the ceiling on what you pay in a year). Cancer treatment is expensive enough that most patients hit their out-of-pocket maximum, which effectively becomes the price tag for the year.
For 2025, the legal cap on out-of-pocket maximums for Marketplace plans is $9,200 for an individual and $18,400 for a family. In 2026, those limits rise to $10,600 and $21,200 respectively. Employer-sponsored plans often have lower maximums, but not always. If your plan sets the maximum at $5,000, that’s roughly what you’ll spend in a year of active treatment. If it’s set at $9,200, you could pay that full amount.
High-deductible health plans deserve special attention here. Among cancer patients who ended up in medical debt, the most common insurance type was a high-deductible plan without a health savings account. These plans keep monthly premiums low but front-load thousands of dollars in costs before coverage begins, which hits hard when you’re suddenly facing scans, biopsies, and treatment within weeks of a diagnosis.
How Costs Differ by Insurance Type
The type of insurance you carry changes your financial exposure significantly. Research on radiation therapy alone found that 100 percent of commercially insured patients hit their annual out-of-pocket maximum during treatment. The average maximum for those commercial plans was about $4,064. That means if you have private insurance and need radiation, you should expect to pay your full annual maximum.
Medicare works differently depending on which parts you have. Traditional Medicare (Part B) covers drugs administered by infusion or injection at a doctor’s office or hospital. Oral chemotherapy drugs, which are increasingly common, may fall under Part B for cancer treatment or under Part D (the prescription drug benefit), and your cost-sharing can differ depending on which part covers the medication. Medicare Advantage plans set their own cost-sharing rules, and the average annual out-of-pocket maximum in those plans runs around $4,661 for radiation therapy. About 55 percent of Medicare Advantage patients hit that ceiling.
If you have Medicare with a supplemental (Medigap) policy, or if you’re on Medicaid, your out-of-pocket costs for radiation are negligible. Medigap policies are specifically designed to cover the gaps in traditional Medicare, and Medicaid has very low cost-sharing by design.
Where the Big Bills Come From
Cancer treatment isn’t one bill. It’s a cascade of charges over months or years: diagnostic imaging, surgical procedures, chemotherapy or immunotherapy (often given in cycles over weeks or months), radiation sessions, follow-up scans, lab work, and sometimes hospitalization. Each of these generates separate charges with separate copays or coinsurance amounts.
The expenses that catch people off guard tend to be the ones that fall outside their primary plan’s coverage or network. A pathology lab that’s out of network, an anesthesiologist you didn’t choose during surgery, or a specialty drug with a high coinsurance percentage can all create unexpected bills. Oral cancer drugs are a common source of sticker shock. Many plans cover them under the pharmacy benefit with percentage-based coinsurance rather than flat copays, meaning a single month’s prescription could cost hundreds or thousands of dollars until you reach your maximum.
Treatment that spans a calendar year boundary resets the clock. If you start chemotherapy in October and finish in March, you may need to meet your deductible and work toward your out-of-pocket maximum twice, once in each plan year. For a treatment course that stretches across two or three years, the cumulative cost can reach well into five figures.
Prior Authorization Can Add Costs
Insurance companies often require prior authorization before approving certain cancer treatments, meaning your doctor must get the insurer’s permission before proceeding. When authorization is denied, you face a difficult choice: pay out of pocket for the recommended therapy, accept an alternative treatment the insurer prefers, or go without. Appeals can take weeks, and during that time, treatment may be delayed. This process doesn’t just create frustration. It can shift costs onto patients who feel pressured to pay for denied treatments themselves rather than wait.
Financial Assistance That Can Lower Your Costs
Drug manufacturers offer copay assistance programs that can dramatically reduce what you pay for specific cancer medications. These programs generally have no income limits, which makes them accessible to a wide range of patients. The catch is that they’re only available to people with commercial or private insurance. If you have Medicare (including Medicare Advantage), Medicaid, or any government insurance product, you don’t qualify, even if your Medicare Advantage plan is administered by a commercial carrier.
For patients on government insurance or without drug-specific assistance, other options exist. Nonprofit organizations like the Patient Advocate Foundation and CancerCare offer grants to help cover treatment costs, copays, and related expenses like transportation. Many hospitals also have financial assistance programs or charity care policies that reduce bills based on income. Social workers in oncology departments are typically the fastest route to finding these resources, and most cancer centers have them on staff specifically for this purpose.
The Realistic Range to Plan For
If you have commercial insurance and are facing active cancer treatment, the most realistic planning number is your plan’s annual out-of-pocket maximum. Look it up on your benefits summary. For most employer plans, that falls between $3,000 and $9,200 for an individual. Expect to hit it, and expect to hit it again if treatment continues into the next calendar year.
Beyond the maximum, budget for costs that don’t always count toward it: out-of-network charges, some prescription copays, dental and vision issues related to treatment side effects, and non-medical costs like transportation, parking at treatment centers, and lost income from missed work. Studies consistently find that the total financial burden of cancer extends well beyond what shows up on medical bills. Planning for your out-of-pocket maximum plus 20 to 30 percent gives a more accurate picture of what a year of cancer treatment will actually cost your household.